References
Go RS, Winters JL, Kay NE (2017) How I treat autoimmune hemolytic anemia. Blood 129:2971–2979
Murphy S, LoBuglio AF (1976) Drug therapy of autoimmune hemolytic anemia. Semin Hematol 13:323–334
Lafarge A, Bertinchamp R, Pichereau C, Valade S, Chermak A, Theodose I, Canet E, Lemiale V, Schlemmer B, Galicier L, Azoulay E, Mariotte E (2019) Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol 98:589–594
Barcellini W (2015) Immune hemolysis: diagnosis and treatment recommendations. Semin Hematol 52:304–312
Guppy M, Greiner E, Brand K (1993) The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 212:95–99
Acknowledgements
Thanks to professor Liu-yi from the hematology hospital of the Chinese Academy of Medical Sciences for offering his help in statistical analysis.
Funding
There was no funding in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that we have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all patients included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shijun Li and Yuan Li are co-first authors of this manuscript.
Rights and permissions
About this article
Cite this article
Li, S., Li, Y. The Characteristics of AIHA Patients Benefited from Glucocorticoid Treatment. Indian J Hematol Blood Transfus 36, 429–431 (2020). https://doi.org/10.1007/s12288-019-01224-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-019-01224-4